BHVN — Biohaven Ltd. stock price, charts and financials

QT50Biohaven Ltd.

Biohaven Ltd. (NYSE: BHVN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.75
+0.38+2.84%
BHVNQT50Biohaven Ltd.·NYSE
13.75+2.84%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 17, 20263Initial statement of beneficial ownership
Jul 09, 20268-KCurrent report
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 27, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 20268-KCurrent report
May 04, 2026424B5Prospectus
May 04, 2026S-3ASRS-3ASR
May 04, 20268-KCurrent report
May 04, 20268-KCurrent report
May 04, 202610-QQuarterly report
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Mar 19, 20264Statement of changes in beneficial ownership
Mar 13, 2026DEFA14AAdditional proxy soliciting materials
Mar 13, 2026DEF 14ADefinitive proxy statement
Mar 09, 20264/AStatement of changes in beneficial ownership (amended)
Mar 03, 20264Statement of changes in beneficial ownership
Mar 03, 20264Statement of changes in beneficial ownership
Mar 03, 20264Statement of changes in beneficial ownership